MRSA Surveillance Programmes Worldwide: Moving towards a harmonised international approach
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F22%3A43922940" target="_blank" >RIV/00064173:_____/22:43922940 - isvavai.cz</a>
Alternative codes found
RIV/75010330:_____/22:00013851 RIV/00216208:11120/22:43922940
Result on the web
<a href="https://doi.org/10.1016/j.ijantimicag.2022.106538" target="_blank" >https://doi.org/10.1016/j.ijantimicag.2022.106538</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ijantimicag.2022.106538" target="_blank" >10.1016/j.ijantimicag.2022.106538</a>
Alternative languages
Result language
angličtina
Original language name
MRSA Surveillance Programmes Worldwide: Moving towards a harmonised international approach
Original language description
Multinational surveillance programmes for methicillin-resistant Staphylococcus aureus (MRSA) are dependent on national structures for data collection. This study aimed to capture the diversity of national MRSA surveillance programmes and propose a framework for harmonisation of MRSA surveillance. The International Society of Antimicrobial Chemotherapy (ISAC) MRSA Working Group conducted a structured survey on MRSA surveillance programmes and organised a webinar to discuss the programmes' strengths and challenges and guidelines for harmonisation. Completed surveys represented 24 MRSA surveillance programmes in 16 countries. Several countries reported separate epidemiological and microbiological surveillance. Informing clinicians and national policymakers were the most common purposes of surveillance. Surveillance of bloodstream infections (BSI) was present in all programmes. Other invasive infections were often included. Three countries reported active surveillance of MRSA carriage. Methodology and reporting of antimicrobial susceptibility, virulence factors, molecular genotyping and epidemiological metadata varied greatly. Current MRSA surveillance programmes rely upon heterogeneous data collection systems, which hampers international epidemiological monitoring and research. To harmonise MRSA surveillance, we suggest improving the integration of microbiological and epidemiological data, implementation of central biobanks for MRSA isolate collection, and inclusion of a representative sample of skin and soft tissue infection cases in addition to all BSI cases.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30303 - Infectious Diseases
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Antimicrobial Agents
ISSN
0924-8579
e-ISSN
1872-7913
Volume of the periodical
59
Issue of the periodical within the volume
3
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
7
Pages from-to
106538
UT code for WoS article
000784446400013
EID of the result in the Scopus database
2-s2.0-85124147392